Cost-effectiveness of prophylactic amiodarone therapy for the prevention of atrial fibrillation in patients undergoing cardiac surgery varies by underlying risk and type of surgery: Results for CABG, valve replacement, and combined CABG and valve replacement Conference

Mahoney, EM, Williams, JK, Veledar, E et al. (2002). Cost-effectiveness of prophylactic amiodarone therapy for the prevention of atrial fibrillation in patients undergoing cardiac surgery varies by underlying risk and type of surgery: Results for CABG, valve replacement, and combined CABG and valve replacement . JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 39(5), 446A-446A.

keywords

  • Cardiac & Cardiovascular Systems
  • Cardiovascular System & Cardiology
  • Life Sciences & Biomedicine
  • Science & Technology

publisher

  • ELSEVIER SCIENCE INC

start page

  • 446A

end page

  • 446A

volume

  • 39

issue

  • 5